0001876708-21-000001.txt : 20210806
0001876708-21-000001.hdr.sgml : 20210806
20210806140710
ACCESSION NUMBER: 0001876708-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210806
DATE AS OF CHANGE: 20210806
EFFECTIVENESS DATE: 20210806
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoImmune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001876708
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-409127
FILM NUMBER: 211152315
BUSINESS ADDRESS:
STREET 1: 251 LITTLE FALLS DRIVE
CITY: WILMINGTON
STATE: DE
ZIP: 19808
BUSINESS PHONE: 4692222350
MAIL ADDRESS:
STREET 1: 251 LITTLE FALLS DRIVE
CITY: WILMINGTON
STATE: DE
ZIP: 19808
D
1
primary_doc.xml
X0708
D
LIVE
0001876708
CytoImmune Therapeutics, Inc.
1218 S 5th Ave
Monrovia
CA
CALIFORNIA
91016
4692222350
DELAWARE
None
None
Corporation
true
2020
Aleksey
Krylov
1218 S 5th Ave
Monrovia
CA
CALIFORNIA
91016
Executive Officer
Will
Rosellini
1218 S 5th Ave
Monrovia
CA
CALIFORNIA
91016
Executive Officer
Richard
T
Santulli
1218 S 5th Ave
Monrovia
CA
CALIFORNIA
91016
Executive Officer
Kinam
Hong
1218 S 5th Ave
Monrovia
CA
CALIFORNIA
91016
Director
Douglas
Williams
1218 S 5th Ave
Monrovia
CA
CALIFORNIA
91016
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-07-23
false
true
true
Preferred Stock can convert to underlying shares of Common Stock.
false
0
Lifesci Capital
168404
Lifesci Capital
168404
250 West 55th St
New York
NY
NEW YORK
10019
NY
NEW YORK
false
100343439
36543424
63800015
false
4
880000
0
0
false
CytoImmune Therapeutics, Inc.
Aleksey Krylov
Aleksey Krylov
Chief Financial Officer
2021-08-06